




Neonatal sep sis is the mo st com mon cau se of neo na tal dea ths wi th hi gh mor ta li ty des pi te treat me nt. Neo na tal sep sis can be clas si fi ed in to two sub-
types de pen di ng upon on set of sympto ms. The re are ma ny fac to rs that ma ke neo na tes mo re sus cep tab le to in fec tion. Signs of sep sis in neo na tes are 
of ten no n-spe ci fi c and hi gh deg ree of sus pi cion is nee ded for ear ly diag no sis. So me la bo ra to ry pa ra me te rs can be hel pful for scree ni ng of neo na tes 
wi th neo na tal sep sis, but none of it is spe ci fi c and sen si tive enou gh to be used sin gly. Diag nos tic approa ch mos tly fo cu ses on his to ry and re view of 
non spe ci fi c sig ns and sympto ms. Anti bio tic treat me nt is the main stay of treat me nt and sup por ti ve ca re is equal ly im por ta nt. The aim of this re view 
is to gi ve an over view of neo na tal sepsis, in clu di ng in ci den ce, etio lo gy, cli ni cal pic tu re, diag nos ti cs and the ra py.
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Bur den of di sea se
Neo na tal sep sis (NS) is sin gle mo st im por ta nt cau-
se of neo na tal deat hs in the com mu ni ty, ac coun ti-
ng for over ha lf of them (1,2). If diag no sed ear ly 
and trea ted ag gres si ve ly it is pos sib le to sa ve mo st 
ca ses of NS (3). NS is de fi  ned as a cli ni cal syndro me 
cha rac te ri zed by sig ns and sympto ms of in fec tion 
wi th or wit hout ac com pa nyi ng bac teremia in the 
fi r st mo nth of li fe. It en com pas ses va rious syste mic 
in fec tio ns of the newbo rn su ch as sep ti cae mia, 
me nin gi tis, pneu mo nia, ar thri tis, os teo mye li tis 
etc., but it does not in clu de su per fi  cial in fec tio ns 
li ke thrush (4). Neo na tal sep sis may be de fi  ned, bo-
th cli ni cal ly and/or mic ro bio lo gi cal ly, by po si ti ve 
blood and/or ce reb ros pi nal fl uid cul tu res (5,6). The 
in ci den ce of cul tu re-pro ven sep sis is ap proxi ma te-
ly 2 per 1,000 li ve bir ths. The re is no uni ver sal ag-
ree me nt on de fi  ni tion of neo na tal sep sis, accor di-
ng to va rious diag nos tic cri te ria, in ci den ce of neo-
na tal sep sis in de ve lo ped coun tries is 2.2-8.6 per 
1,000 li ve bir ths (7-9). Ba bies in the neo na tal in ten-
si ve ca re units (NICU) are at in crea sed ri sk for acqui-
ri ng no so co mial (hos pi ta l-a cqui red) in fec tio ns. 
Ma ny ba bies in the NICU are pre ma tu re or ha ve 
low bir thweig ht whi ch ma kes them mo re sus ce-
ptable to in fec tion and mo re li ke ly to need in va si-
ve treat men ts and pro ce du res. No so co mial blood 
stream in fec tio ns con ti nue to be a cau se of hi gh 
mor ta li ty and mor bi di ty in NI CUs (10).
Ear ly vs. late sep sis
Neo na tal sep sis can be clas si fi ed in to two su b-
types de pen di ng upon whet her the on set of 
sympto ms is be fo re 72 hou rs of li fe (ear ly on set) or 
la ter (la te on set). Ear ly-on set in fec tio ns are cau sed 
by or ga nis ms pre va le nt in the mater nal ge ni tal tra-
ct or in the de li ve ry area. Ri sk fac to rs for ear ly-on-
set sep sis in clu de pre ma tu ri ty, low bir th weig ht, 
pre ma tu re and pro lon ged rup tu re of mem bra nes, 
ma ter nal fe ver, uroin fec tion and cho rioam nio ni tis.
La te-on set sep sis (LOS) is cau sed by the or ga nis ms 
thri vi ng in the exter nal en vi ron me nt of the ho me 
or the hos pi tal. The in fec tion is of ten tran smit ted 
throu gh the han ds of the ca re-pro vi de rs. The on-
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set of sympto ms is usual ly de layed beyo nd 72 hou-
rs af ter bir th and the pre sen ta tion is that of sep ti-
ce mia, pneu mo nia or me nin gi tis. LOS is a com mon 
com pli ca tion of pro lon ged ad mis sion to the NICU 
fol lowi ng pre te rm bir th (11). Risk fac to rs for LOS 
are in va si ve pro ce du res su ch as re sus ci ta tion in 
de li ve ry room, in tu ba tion, mec ha ni cal ven ti la tion, 
central ve nous cat he te rs, sur gi cal pro ce du res and 
stayi ng in NI CUs for pro lon ged pe riod of ti me. The 
use of broad spec trum an ti bio ti cs is ri sk fac tor for 
fun gal NS.
Cau sa ti ve agen ts of sep sis
The mic roor ga nis ms mo st com mon ly as so cia ted 
wi th ear ly on set infec tion in clu de group B Strep to-
coc cus (GBS), Es che ric hia co li, coa gu la se ne ga ti ve 
Stap hylo coc ci (CONS), Hae mop hi lus in fl uen zae and 
Lyste ria mo no cyto ge nes (12).
Group B strep to coc cus arised as an im por ta nt cau-
se of neo na tal and ma ter nal pat ho gen in USA & 
Wes te rn Eu ro pe wi th re por ted mor ta li ty ra te of 15-
50% (13). In the USA 10-35% of preg na nt wo men 
are asympto ma tic car rie rs of GBS in ge ni tal and 
gas tro in tes ti nal tra ct at the ti me of de li ve ry (14). 
Ap proxi ma te ly 98% of co lo ni zed newbo rn re main 
heal thy but 1-2% de ve lop in va si ve GBS in fec tion. 
The ove ra ll in ci den ce of neo na tal GBS in fec tion 
was ap proxi ma te ly 2/1,000 li ve bir ths in the USA 
prior to in tro duc tion of in tra-par tum prop hylaxis. 
Tren ds in the epi de mio lo gy of ear ly on set sep sis 
show a dec rea si ng in ciden ce of GBS sep sis (15). Af-
ter in tro duc tion of in tra par tal prop hy laxis again st 
GBS in fec tion the re was a sig ni fi  ca nt dec li ne in ear-
ly GBS NS in newbor ns le ss than 1500 g bir thweig-
ht (16). GBS re mai ns the mo st freque nt sig ni fi  ca nt 
pat ho gen in te rm in fan ts and E. co li the mo st sig ni-
fi  ca nt pat ho gen in pre te rm in fan ts (17).
La te on set sep sis syndro me oc cu rs at 7-90 days of 
li fe and is acqui red from the ca re gi vi ng en vi ron-
me nt. Or ga nis ms that are as so cia ted wi th la te on-
set sep sis are Stap hylo co ccus au reus, CONS, E. co li, 
Kle bsiel la, Pseu do mo nas, En te ro bac ter, Candi da, 
GBS, Ser ra tia, Aci no bac ter and anaerobes. Tren ds in 
la te-on set sep sis show an in crea se in CONS sep sis 
(17). Late on set di sea se has a hig her ca se fa ta li ty 
ra te when gram ne ga ti ve bac te ria are in vol ved.
Sus cep ta bi li ty for neo na tal in fec tion
The fe tus has so me pre for med im mu nog lo bu lin 
pre se nt, pri ma ri ly acqui red throu gh non spe ci fi c 
pla cen tal tran sfer from the mot her. Mo st of this 
tran sfer oc cu rs in la te ges ta tion, su ch that lower 
le ve ls are fou nd wi th in crea si ng pre ma tu ri ty. The 
neo na te may re cei ve im mu nog lo bu lin A (IgA) from 
breas tfee di ng but does not sec re te IgA un til 2-5 
wee ks af ter bir th. Concen tra tion of va rious com-
po nen ts of the com ple me nt system wi de ly varies 
amo ng in di vi dual neo na tes. The ter minal cyto-
toxic com po nen ts of the com ple me nt cas ca de 
that lea ds to kil li ng of or ga nis ms, es pe cial ly gra m-
nega ti ve bac te ria, are de fi  cient. Natu ral kil ler (NK) 
cel ls are fou nd in sma ll num be rs in the pe rip he ral 
blood of neo na tes. The se cel ls are al so fun ctionally 
im ma tu re in a way that they pro du ce far lower le-
ve ls of in ter fe ro n-gam ma upon pri ma ry sti mu la-
tion than do adu lt NK cel ls. The physi cal and che-
mi cal bar rie rs to in fec tion in the hu man bo dy are 
pre se nt in the newbo rn but are fun ctio nal ly de fi -
cie nt. Skin and mucus mem bra nes are bro ken 
down ea si ly in pre ma tu re in fan ts.
Cli ni cal fea tu res
Sig ns of sep sis in neo na tes are of ten non spe ci fi c 
(Tab le 1). It is im por ta nt to re cog ni se sig ns and 
sympto ms of pos sib le in fec tion to ma ke ear ly diag-
no sis. A neo na te wi th sepsis may pre se nt wi th sig-
ns and sympto ms of hypot her mia or fe ver, poor 
cry, poor fee di ng or re fu sal to su ck, let har gy, hypo-
to nia, res pi ra to ry dis tre ss, ap nea, fa st breat hi ng, 
poor per fu sion, hypog lycae mia and pro lon ged ca-
pil la ry re fi  ll ti me. Me nin gi tis is often si le nt, the cli-
ni cal pic tu re is do mi na ted by ma ni fes ta tio ns of as-
so cia ted sep ti ce mia.
The eva lua tion te st for neo na tal sep sis is im por ta-
nt be cau se in fec tion indi ca tes a ve ry se rious threat 
to ba bies. The re is no sin gle te st that can be con fi -
den tly used and ap plied by physi cia ns/neonatolo-
gists to pre di ct neo na tal sep sis. Mo st of the diag-
nos tic tes ts are not avai lab le in se con da ry and pri-
ma ry ca re le vel. So the diag nos tic ap proa ch fo cu-
ses on his to ry and re view of non spe ci fi c sig ns and 
sympto ms (18,19).
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Diag nostic too ls for neo na tal sep sis
The iso la tion of mic roor ga nis ms from blood, ce-
reb ros pi nal fl uid (CSF) or uri ne re mai ns the go ld 
stan da rd for de fi  ni ti ve diag no sis, howe ver, con fi r-
ma tion or exclu sion of po si ti ve cul tu res requi res 
days and the sensiti vi ty of the cul tu re met ho ds is 
frequen tly low be cau se of the con co mi ta nt an ti-
bio tic the ra py, sma ll blood sam ple vo lu me or low 
co lo ny coun ts. In ad di tion, cli ni cal sig ns of sep sis 
in neo na tes are poor, la te and non spe ci fi c, par ti-
cu la ry in pre te rm in fants, in whom the on set of 
sep sis may be acu te and cli ni cal cour se can quic kly 
de te rio ra te.
If pos sib le, lum bar pun ctu re shou ld be do ne in all 
ca ses of la te on set (> 72 hou rs) and sympto ma tic 
ear ly on set sep sis be cau se 10-15 per ce nt of chil-
dren may ha ve as socia ted me nin gi tis. De tec ti ng 
me nin gi tis in sep ti ce mia is im por ta nt be cau se of 
the need for usi ng an ti bio ti cs wi th a hi gh CSF pe-
net ra tion and pro vi sion of an ti bio tic treat me nt for 
at lea st 3 wee ks pa ren te ral ly.
Non spe ci fi c la bo ra to ry in ves ti ga tion for the diag-
no sis of in va si ve bac te rial in fec tio ns re main the 
mo st im por ta nt diag nos tic aid for the ma na ge me-
nt of sep tic neo na tes (20) (Tab le 2).
The ro le of la bo ra to ry re sul ts and their no ti fi  ca tion 
of cri ti cal va lues can so me ti mes be crucial in the 
ma na ge me nt of the pa tie nt. The re fo re, all eff or ts 
need to be ma de in or der to es tab li sh the ap prop-
ria te li nk be tween la bo ra to ry and the cli nic in ter-
ms of the ti me ly notifi  ca tion of the cri ti cal va lues 
for a cri ti cal ly ill pa tie nt. The cri te ria for con si de ri-
ng te st re sults cri ti cal is con tro ver sal (21). The re are 
a va rie ty of tes ts whi ch are hel pful for scree ni ng of 
neo na tes wi th sep sis. The mo st use ful and wi de ly 
used is the whi te blood ce ll cou nt and diff e ren tial 
cou nt. Neut ro pe nia is mo re pre dic ti ve of neo na tal 
sep sis than neut rop hi lia, but it may be pre se nt in 
ma ter nal hyper ten sion, bir th as phyxia and pe ri-
ven tri cu lar he mor r ha ge. To tal leu ko cyte cou nt (> 20 
and < 5 x 109 / L), diff e ren tial leu ko cyte cou nt and 
mor pho lo gy, to tal neut rop hil cou nt, to tal non seg-
TAB LE 1. Cli ni cal ma ni fes ta tio ns of neo na tal sep sis.
Cli ni cal ma ni fes ta tio ns of neo na tal sep sis
Let har gy 
Refusal to suc kle 
Poor cry 
Not arou sab le, co ma to sed 
Ab do mi nal dis ten sion 
Diar r hea 
Vo mi ti ng 
Hypot her mia 
Poor per fu sion 
Scle re ma 
Poor weig ht gain 
Sho ck 
Blee di ng 
Re nal fai lu re 
Cya no sis
Tac hypnea 






Hi gh pit ched cry
Exces si ve cryi ng/irritability
Ne ck ret rac tion
Bul gi ng fon ta nelle
TAB LE 2. La bo ra to ry in ves ti ga tio ns for diag no sis of neo na tal 
sep sis.
Spe ci fi c la bo ra to ry tes ts
Blood, ce reb ros pi nal fl uid and uri ne cul tu re
Di re ct vi sua li sa tion of bac te ria (Gram stai n…)
De tec tion of bac te rial an ti ge ns
Po lyme ra se chain reac tion (am pli fi  ca tion of bac te rial DNA)
Hae ma to lo gi cal in ves ti ga tio ns
Whi te blood ce ll coun ts, to tal and diff e ren tial, pla te let cou nt
Bioc he mi cal inves ti ga tio ns
CRP, pro cal ci to nin, ESR, se rum amyloid, ot her acu te pha se 
reac tan ts: hap tog lo bin, lac to fer rin, neop te rin, in te r-in hi bi tor 
pro tei ns (I I ps), li po po lysac cha ri de-bin di ng pro tein (LBP), C5a, 
C5L2, im mu nog lo bu li ns
Cyto ki nes and re cep to rs
IL-1, IL-6, IL-8, IL-10
IL-1ra, IL-2rs
IP-10, RANTES, TNF-α, I FN-γ
G-CSF, CSF1, SCF
MI P1-a
sCD14, sI CA M-1, CD11b, CD64, CD69, CD25, CD45RO, CD19, 
CD33, CD66b
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men ted neut rop hil cou nt, neuot rop hil ra tios, pla te-
let cou nt are the in di ces mo st com mon ly used. The-
se hae ma to lo gi cal coun ts and ra tios showed a li mi-
ted ac cu ra cy wi th wi de ran ge of sen si ti vi ty (17-
90%) and spe ci fi  ci ty (31-100%), due to the re la ti ve ly 
lo ng pe riod ne ces sa ry to be co me po si ti ve and the 
sig ni fi  ca nt in fl uen ce of no n-spe ci fi c fac to rs. Howe-
ver, the bands neut rop hil: to tal neut rop hil (IT) ra tio 
of > 0.2 may rea ch a sen si ti vi ty of 90% and the ne-
ga ti ve pre dic ti ve va lue of 98%. The IT ra tio is le ss in-
fl uen ced by non infec tious fac to rs, as the met hod 
of de li ve ry (22). Pla te let cou nt of le ss than 100 x 109 
/ L can be in di re ct evi den ce of in fec tion.
C-Reac ti ve Pro tein (CRP) is a globulin that for ms a 
pre ci pi ta te when com bi ned wi th the C-po lysac-
cha ri de of Strep to coc cus pneumo niae. It is the mo st 
exten si ve ly acu te pha se reac ta nt stu died so far. 
The sen si ti vi ty is low for ear ly diag no sis of sep sis, 
due to the re la ti ve ly lo ng ti me, 6-8 hou rs fol lowi ng 
the sti mu lus, requi red for the synthe sis; the peak is 
ob ser ved at 24 hou rs. The qua li ta ti ve as say of CRP 
does not off er sig ni fi  ca nt ad van ta ges on the leu-
ko cyte in dexes. On the ot her ha nd, quan ti ta ti ve 
CRP va lues, par ti cu lar ly when re pea ted, are hig hly 
spe ci fi c and ha ve good sen si ti vi ty. In ad di tion, se-
rial mea su re men ts can be helpful in mo ni to ri ng 
the res pon se to treat me nt. In spi te of the re du ced 
ear ly sen si ti vi ty, CRP sti ll re mai ns the pre fer red in-
dex in mo st neo na tal ICUs.
Ve ry hi gh se rum procal ci to nin le ve ls are pre se nt in 
neo na tes wi th pro ven or cli ni cal ly diag no sed bac-
te rial in fec tion; ear ly dec rea se of the se con cen tra-
tio ns refl ec ts ap prop ria te an ti bio tic the ra py (23). 
Com pa red wi th CRP, pro cal ci to nin has the ad van-
ta ge that in crea ses mo re ra pid ly. Howe ver, in com-
pa ri son to the CRP it’s usa ge has been li mi ted be-
cau se of sig ni fi ca nt ra pid va ria tio ns of ba sal le ve ls 
af ter bir th, and the need for se ve ral diff e re nt cu t-
o ff  va lues wi th chan gi ng neo na tal age (24). Rece nt 
me ta-a na lysis sug ges ted that pro cal ci to nin 
showed bet ter ac cu ra cy than the CRP te st for the 
diag no sis of la te-on set sep sis (25). PCT con cen tra-
tion showed bet ter dis cri mi na tion than ot her in-
fl am ma to ry pa ra me te rs for diff e ren tia ti ng syste-
mic from lo ca li sed bac te rial in fec tion in cri ti cal ly ill 
pa tien ts (26). Pro cal ci to nin shou ld be used as an 
ad jun ct, rat her than a rep lace me nt, to CRP to im-
pro ve the diag nos tic ac cu ra cy.
An im por ta nt li mit of hae ma to lo gi cal in di ces for 
ear ly diag no sis of sep sis is the ti me requi red for 
the te st to be co me po si ti ve. It ta kes se ve ral hou rs 
for leu ko cyte in di ces and acu te-pha se reac tan ts to 
chan ge sig ni fi  can tly af ter the on set of reac tion.
Se ve ral cyto ki nes and re cep to rs ha ve been eva lua-
ted for the ear ly diag no sis of in fec tion in neo na tes 
(27-32). In mo st ca ses of neo na tal sep sis, in ter-
leukin-6 (IL-6) in crea ses ra pid ly, se ve ral hou rs be-
fo re the in crea se in the con cen tra tion of CRP, and 
dec rea ses wit hin 24 hou rs to un de tec tab le le ve ls. 
IL-6 has good sen si ti vi ty and good spe ci fi  ci ty when 
used as a ve ry ear ly mar ker. A stu dy showed that 
IL-6 and in te rleuki n-1 re cep tor an ta go ni st (IL-1ra) 
in crea sed sig ni fi  can tly two days be fo re cli ni cal 
diag no sis of sep sis (27). In con tra st to CRP, IL-6 is 
ve ry ear ly mar ker but le ve ls can be co me nor mal 
even if in fec tion con ti nues. When used in com bi-
na tion wi th CRP, the sen si ti vi ty is hi gh for in fec ted 
in fan ts at any pos tna tal age.
Treat me nt
No in ves ti ga tion is requi red to sta rt treat me nt in a 
cli ni cal ly ob vious ca se. Ear ly treat me nt is cru cial. 
Sup por ti ve ca re and an ti bio ti cs are two equal ly 
im por ta nt com po nen ts of the treat me nt. It shou ld 
be rea li zed that an ti bioti cs ta ke at lea st 12 to 24 
hou rs to show any eff e ct and it is the sup por ti ve 
ca re that ma kes the diff e ren ce be tween li fe and 
dea th ear ly in the hos pi tal cour se. The purpo se of 
sup por ti ve ca re is to nor ma li ze the tem pe ra tu re, 
sta bi li ze the car dio pul mo na ry sta tus, cor re ct 
hypog lyce mia and pre ve nt blee di ng ten den cy.
The re is no sin gle re com men da tion for an ti bio tic 
re gi men for neo na tal sep sis for all set tin gs. Ge ne-
ral ly the choi ce of an ti bio tic de pen ds on sus pec ted 
fl o ra in the gi ven set up and their an ti micro bial sus-
cep ti bi li ty. An ti bio tic the ra py is star ted when the re 
is stro ng sus pi cion of sep sis. Choi ce of an ti bio tic al-
so de pen ds on sour ce of in fec tion. A com bi na tion 
of am pi cil lin or pe ni cil lin wi th gen ta mi cin may be 
used as fi r st li ne of the ra py for communi ty acqui red 
in fec tion whe re re sis ta nt strai ns are le ss li ke ly. For 
hos pi tal acqui red in fec tion whe re re sis ta nt strai ns 
are mo re li ke ly a com bi na tion of am pi cil lin or cloxa-
cil lin and gen ta mi cin or ami ka cin may be used (33).
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An ti bio tic the ra py shou ld cover the com mon cau-
sa ti ve bac te ria - Es che ric hia co li, Stap hylo coc cus au-
reus and Kleb siel la pneu mo niae. A com bi na tion of 
am pi cil lin and gen ta mi cin is re com men ded for 
treat me nt of sep sis and pneu mo nia. In ca ses of 
sus pec ted me nin gi tis, ce fo taxi me shou ld be used 
alo ng wi th an ami nog lyco si de. Tab le 3 shows gui-
de li nes about an ti bio tic the ra py. The du ra tion of 
an ti bio tic the ra py in sep sis de pen ds upon the pat-
ho gen, si te of in fec tion and the cli ni cal res pon se 
of the ba by. 7-10 days the ra py is requi red for so ft 
ti ssue in fec tio ns or pneu mo nia. Dee p-sea ted in-
fec tio ns (os teo mye li tis) and me nin gi tis may requi-
re the ra py for 3-6 wee ks.
Pre ven tion of in fec tio ns
A good an te na tal ca re is importa nt in dec rea si ng the 
in ci den ce, mor bi di ty and mor ta li ty from neo na tal 
sep sis. All types of in fec tio ns shou ld be diag no sed 
ear ly and trea ted vi go rous ly in preg na nt mot he rs.
Con clu sion
In con clu sion, ma ni fes ta tio ns of neo na tal sep sis 
are no n-spe ci fi c. A hi gh in dex of sus pi cion wi th or 
wit hout lab evi den ces of in fec tion is the key for 
ear ly diag no sis. Prom pt in sti tu tion of an ti bio tic 
the ra py and sup por ti ve ca re wi ll sa ve mo st of the 
ca ses of neo na tal sep sis.
Po ten tial con fl i ct of in te re st
No ne dec la red.
An ti bio tic Ea ch do se(mg/kg)
Frequen cy
< 7 days age
Frequen cy
> 7 days age Rou te Du ra tion
Sep ti ce mia or 
pneu mo nia
Inj Am pi cil lin or 50
12 hour ly 8 hour ly
IV, IM
7-10 days
Inj Cloxa cil lin 50 IV
AND
Inj Gen ta mi cin or 2.5 IV, IM
Inj Ami ka cin 7.5 IV, IM
Me nin gi tis
Inj Am pi cil lin 100
12 hour ly 8 hour ly IV 3 wee ks
AND
Inj Gen ta mi cin 2.5
OR
Inj Ce fo taxi me
AND
50
Inj Gen ta mi cin 2.5
TAB LE 3. An ti bio tic the ra py of neo na tal sep sis.
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No vo rođenačka sep sa
Sažetak
No vo rođenačka sep sa je na jče šći uz rok smr tnos ti no vo rođe nčadi s vi so kom sto pom smr tnos ti us pr kos te ra pi ji. Pre ma počet ku jav lja nja kli ničkih 
zna ko va raz li ku je se ra na i kas na sep sa. Mno go je čim be ni ka zbog ko jih je no vo rođe nče oso bi to pod ložno in fek ci ji. Zna ko vi sep se u no vo rođenačkoj 
do bi čes to su nes pe ci fi čni i pot reb na je os no va na sum nja za ra no pos tav lja nje di jag no ze. U pro bi ru no vo rođe nčadi sa sum njom na sep su ko ris te 
se od ređeni la bo ra to rij ski para met ri, no niti je dan ni je do volj no spe ci fi čan i os jet ljiv da bi se ko ris tio sa mos tal no. Di jag nos tički pris tup zas ni va se 
na anam ne zi i ana li zi nes pe ci fi čnih zna ko va. Os nov na te ra pi ja su an ti bio ti ci, pot por no li ječenje je jed na ko važno. Cilj ra da je da ti preg led no vo-
rođenačke sep se, uk ljučujući in ci den ci ju, etio lo gi ju, kli ničku sli ku, di jag nos ti ku i te ra pi ju.
Ključne ri ječi: in fek ci ja; no vo rođe nče; sep sa; an ti bio ti ci
